{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:27:44Z","timestamp":1790015264352,"version":"4.0.1"},"reference-count":306,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32300788"],"award-info":[{"award-number":["32300788"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2024MC119"],"award-info":[{"award-number":["ZR2024MC119"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR202111120048"],"award-info":[{"award-number":["ZR202111120048"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022QH201"],"award-info":[{"award-number":["ZR2022QH201"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023QH173"],"award-info":[{"award-number":["ZR2023QH173"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023QH020"],"award-info":[{"award-number":["ZR2023QH020"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.intimp.2026.116842","type":"journal-article","created":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T09:32:40Z","timestamp":1779010360000},"page":"116842","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Advanced platforms for antibody delivery: Overcoming biological barriers and improving therapeutic performance"],"prefix":"10.1016","volume":"182","author":[{"given":"Yumeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanpeng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bixiao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.intimp.2026.116842_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104198","article-title":"Polybodies: next-generation clinical antibodies","volume":"29","author":"Pande","year":"2024","journal-title":"Drug Discov. Today"},{"issue":"18","key":"10.1016\/j.intimp.2026.116842_bb0010","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1158\/1078-0432.CCR-15-0996","article-title":"Cancer immunotherapy: more is (much) better","volume":"21","author":"Yarden","year":"2015","journal-title":"Clinical cancer research\u202f: an official journal of the American Association for Cancer Research."},{"issue":"23","key":"10.1016\/j.intimp.2026.116842_bb0015","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.7150\/thno.49480","article-title":"Combination therapy with B7H3-redirected bispecific antibody and sorafenib elicits enhanced synergistic antitumor efficacy","volume":"10","author":"Huang","year":"2020","journal-title":"Theranostics"},{"issue":"34","key":"10.1016\/j.intimp.2026.116842_bb0020","doi-asserted-by":"crossref","first-page":"8786","DOI":"10.1200\/JCO.2005.03.1997","article-title":"Multicenter phase I\/II study of cetuximab with paclitaxel and carboplatin in untreated patients with stage IV non-small-cell lung cancer","volume":"23","author":"Thienelt","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.intimp.2026.116842_bb0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2217\/lmt-2016-0013","article-title":"Combination approaches in NSCLC involving immune checkpoint inhibitors","volume":"5","author":"Arulananda","year":"2016","journal-title":"Lung cancer management."},{"key":"10.1016\/j.intimp.2026.116842_bb0030","doi-asserted-by":"crossref","first-page":"1279221","DOI":"10.3389\/fimmu.2023.1279221","article-title":"Photothermally sensitive gold nanocage augments the antitumor efficiency of immune checkpoint blockade in immune \u201ccold\u201d tumors","volume":"14","author":"Xiao","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116842_bb0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11095-019-2689-1","article-title":"In vivo stability of therapeutic proteins","volume":"37","author":"Schuster","year":"2020","journal-title":"Pharm. Res."},{"issue":"6","key":"10.1016\/j.intimp.2026.116842_bb0040","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/j.xphs.2021.03.007","article-title":"Stability of monoclonal antibodies after simulated subcutaneous administration","volume":"110","author":"Schuster","year":"2021","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2026.116842_bb0045","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s40259-014-0104-3","article-title":"Human immunoglobulin 10% with recombinant human hyaluronidase: replacement therapy in patients with primary immunodeficiency disorders","volume":"28","author":"Sanford","year":"2014","journal-title":"BioDrugs\u202f: clinical immunotherapeutics, biopharmaceuticals and gene therapy."},{"key":"10.1016\/j.intimp.2026.116842_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/pharmaceutics10030083","article-title":"Overview of Antibody Drug Delivery","volume":"10","author":"Awwad","year":"2018","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.intimp.2026.116842_bb0055","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.nurt.2008.05.013","article-title":"Targeting beta-amyloid pathology in alzheimer\u2019s disease with abeta immunotherapy","volume":"5","author":"Nitsch","year":"2008","journal-title":"Neurotherapeutics\u202f: the journal of the American Society for Experimental NeuroTherapeutics."},{"issue":"15","key":"10.1016\/j.intimp.2026.116842_bb0060","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1158\/0008-5472.CAN-21-0952","article-title":"Improving tumor penetration of antibodies and antibody-drug conjugates: taking away the barriers for trojan horses","volume":"81","author":"van Dongen","year":"2021","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.intimp.2026.116842_bb0065","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1111\/cas.14983","article-title":"Barriers to antibody therapy in solid tumors, and their solutions","volume":"112","author":"Matsumura","year":"2021","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb0070","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11095-021-03158-x","article-title":"Fc\u03b3 receptor-dependent internalization and off-target cytotoxicity of antibody-drug conjugate aggregates","volume":"39","author":"Aoyama","year":"2022","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb0075","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12929-025-01190-2","article-title":"Technological advancements in antibody-based therapeutics for treatment of diseases","volume":"32","author":"Lu","year":"2025","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.intimp.2026.116842_bb0080","series-title":"The Pharmaceutical Industry in 2025: An Analysis of FDA Drug Approvals from the Perspective of Molecules","author":"de la Torre","year":"2026"},{"key":"10.1016\/j.intimp.2026.116842_bb0085","doi-asserted-by":"crossref","first-page":"113562","DOI":"10.1016\/j.jconrel.2025.02.058","article-title":"Nanobody-based drug delivery systems for cancer therapy","volume":"381","author":"Liu","year":"2025","journal-title":"J. Control. Release."},{"issue":"10","key":"10.1016\/j.intimp.2026.116842_bb0090","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2174\/1386207323666201218115850","article-title":"Virus as a nanocarrier for drug delivery redefining medical therapeutics - a status report","volume":"25","author":"Ojha","year":"2022","journal-title":"Comb. Chem. High Throughput Screen."},{"issue":"11","key":"10.1016\/j.intimp.2026.116842_bb0095","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S1359-6446(03)02699-0","article-title":"Targeted drug delivery systems for the intracellular delivery of macromolecular drugs","volume":"8","author":"Koning","year":"2003","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.intimp.2026.116842_bb0100","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.addr.2020.09.003","article-title":"When liposomes met antibodies: drug delivery and beyond","volume":"154-155","author":"Di","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb0105","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2026.116842_bb0110","doi-asserted-by":"crossref","first-page":"401","DOI":"10.18433\/J3CP55","article-title":"Liposomal drug delivery: a versatile platform for challenging clinical applications","volume":"17","author":"Madni","year":"2014","journal-title":"Journal of pharmacy & pharmaceutical sciences\u202f: a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb0115","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijpharm.2015.08.048","article-title":"Nanoliposome-mediated targeting of antibodies to tumors: IVIG antibodies as a model","volume":"495","author":"Nikpoor","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.intimp.2026.116842_bb0120","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.actbio.2025.02.035","article-title":"Subcutaneous liposomal delivery improves monoclonal antibody pharmacokinetics in vivo","volume":"195","author":"Maryam","year":"2025","journal-title":"Acta Biomater."},{"issue":"5","key":"10.1016\/j.intimp.2026.116842_bb0125","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/IAE.0b013e3181a2f42a","article-title":"Preparation, characterization, and in vivo evaluation of nanoliposomes-encapsulated bevacizumab (avastin) for intravitreal administration","volume":"29","author":"Abrishami","year":"2009","journal-title":"Retina (Philadelphia, Pa)."},{"issue":"8","key":"10.1016\/j.intimp.2026.116842_bb0130","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/smll.201303433","article-title":"Topical delivery of avastin to the posterior segment of the eye in vivo using annexin a5-associated liposomes","volume":"10","author":"Davis","year":"2014","journal-title":"Small (Weinheim an der Bergstrasse, Germany)."},{"issue":"696","key":"10.1016\/j.intimp.2026.116842_bb0135","doi-asserted-by":"crossref","first-page":"eabm1262","DOI":"10.1126\/scitranslmed.abm1262","article-title":"Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia","volume":"15","author":"Moles","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.intimp.2026.116842_bb0140","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1021\/acsptsci.4c00197","article-title":"Generation of anti-epidermal growth factor receptor-2 (HER2) immunoliposomes using microbial transglutaminase (mTG)-mediated site-specific conjugated antibodies","volume":"7","author":"B\u00e9rot","year":"2024","journal-title":"ACS pharmacology & translational Science."},{"issue":"17","key":"10.1016\/j.intimp.2026.116842_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202307865","article-title":"Anti-HER2 immunoliposomes: antitumor efficacy attributable to targeted delivery of Anthraquinone-fused enediyne","volume":"11","author":"Feng","year":"2024","journal-title":"Advanced Science."},{"issue":"2","key":"10.1016\/j.intimp.2026.116842_bb0150","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/08982104.2023.2248505","article-title":"Antibody-conjugated pH-sensitive liposomes for HER-2 PositiveBreast cancer: development, characterization, in vitro and in vivo assessment","volume":"34","author":"Raikwar","year":"2023","journal-title":"Journal of liposome Research"},{"key":"10.1016\/j.intimp.2026.116842_bb0155","author":"Open-label"},{"issue":"3","key":"10.1016\/j.intimp.2026.116842_bb0160","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11095-021-02986-1","article-title":"Targeted delivery of combination therapeutics using monoclonal antibody 2C5-modified immunoliposomes for cancer therapy","volume":"38","author":"Narayanaswamy","year":"2021","journal-title":"Pharm. Res."},{"issue":"11","key":"10.1016\/j.intimp.2026.116842_bb0165","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3390\/pharmaceutics16111444","article-title":"Inhalable anti-EGFR antibody-conjugated osimertinib liposomes for non-small cell lung cancer","volume":"16","author":"Apoorva","year":"2024","journal-title":"Pharmaceutics."},{"issue":"12","key":"10.1016\/j.intimp.2026.116842_bb0175","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S1470-2045(12)70476-X","article-title":"Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study","volume":"13","author":"Mamot","year":"2012","journal-title":"Lancet."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb0180","doi-asserted-by":"crossref","first-page":"100365","DOI":"10.1016\/j.esmoop.2021.100365","article-title":"Targeting immunoliposomes to EGFR-positive glioblastoma","volume":"7","author":"Kasenda","year":"2022","journal-title":"ESMO Open."},{"key":"10.1016\/j.intimp.2026.116842_bb0185","doi-asserted-by":"crossref","first-page":"124772","DOI":"10.1016\/j.talanta.2023.124772","article-title":"Chlorin e6 (ce6)-loaded plaque-specific liposome with enhanced photodynamic therapy effect for atherosclerosis treatment","volume":"265","author":"Zou","year":"2023","journal-title":"Talanta."},{"key":"10.1016\/j.intimp.2026.116842_bb0190","doi-asserted-by":"crossref","first-page":"113237","DOI":"10.1016\/j.colsurfb.2023.113237","article-title":"Improved Targeting Delivery of WED-Load Immunoliposomes Modified with SP-A mAb for the Treatment of Pulmonary Fibrosis","volume":"224","author":"Zhao","year":"2023","journal-title":"Colloids and Surfaces B: Biointerfaces."},{"issue":"11","key":"10.1016\/j.intimp.2026.116842_bb0195","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1021\/acsabm.4c00923","article-title":"Therapeutic suppression of atherosclerotic burden and vulnerability via dll4 inhibition in plaque macrophages using dual-targeted liposomes","volume":"7","author":"Du","year":"2024","journal-title":"ACS Appl. Bio Mater."},{"issue":"2","key":"10.1016\/j.intimp.2026.116842_bb0200","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3390\/ijms27020729","article-title":"BTK-inhibitor loaded polymeric nanoparticles alleviate systemic lupus erythematosus by targeting elimination of autoreactive BAFFRhigh b cells","volume":"27","author":"Zhang","year":"2026","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.intimp.2026.116842_bb0205","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1039\/D2RA00071G","article-title":"Liposome-based nanocapsules for the controlled release of dietary curcumin: PDDA and silica nanoparticle-coated DMPC liposomes enhance the fluorescence efficiency and anticancer activity of curcumin","volume":"12","author":"Othman","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.intimp.2026.116842_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125237","article-title":"Modeling based dynamics mechanism and pathway of liposome penetration in multicellular tumor spheroid for liposome optimization","volume":"671","author":"Liu","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.intimp.2026.116842_bb0215","first-page":"1","volume":"16","author":"Jiang","year":"2023","journal-title":"Lipid-Based Nanotechnology: Liposome. Pharmaceutics."},{"issue":"40","key":"10.1016\/j.intimp.2026.116842_bb0220","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.2174\/0113816128263001231102053654","article-title":"Localized delivery of bioactives using structured liposomal gels","volume":"29","author":"Kumar","year":"2023","journal-title":"Curr. Pharm. Des."},{"issue":"4","key":"10.1016\/j.intimp.2026.116842_bb0225","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1080\/21645515.2015.1116656","article-title":"Transdermal immunization of p. falciparum surface antigen (MSP-119) via elastic liposomes confers robust immunogenicity","volume":"12","author":"Tyagi","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.intimp.2026.116842_bb0230","doi-asserted-by":"crossref","first-page":"112202","DOI":"10.1016\/j.matdes.2023.112202","article-title":"Engineering nanoliposomes to enhance cancer immunotherapy by reversing immunosuppression and synergistically boosting tumour immunogenicity","volume":"233","author":"Zhang","year":"2023","journal-title":"Mater. Des."},{"issue":"2","key":"10.1016\/j.intimp.2026.116842_bb0235","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/nano10020190","article-title":"Immunological and toxicological considerations for the design of liposomes","volume":"10","author":"Inglut","year":"2020","journal-title":"Nanomaterials."},{"issue":"3","key":"10.1016\/j.intimp.2026.116842_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15030801","article-title":"Dendrimer-mediated delivery of anticancer drugs for colon cancer treatment","volume":"15","author":"Rai","year":"2023","journal-title":"Pharmaceutics"},{"issue":"41","key":"10.1016\/j.intimp.2026.116842_bb0245","article-title":"A PD-L1 antibody-conjugated PAMAM dendrimer nanosystem for simultaneously inhibiting glycolysis and promoting immune response in fighting breast cancer","volume":"35","author":"Zhang","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.intimp.2026.116842_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111845","article-title":"PAMAM dendrimers functionalised with an anti-TNF \u03b1 antibody and chondroitin sulphate for treatment of rheumatoid arthritis","volume":"121","author":"Oliveira","year":"2021","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb0255","first-page":"221","article-title":"Surface modified and rituximab functionalized PAMAM g4 nanoparticle for targeted imatinib delivery to leukemia cells: In vitro studies","volume":"111","author":"Parastoo","year":"2021","journal-title":"Process Biochem."},{"issue":"9","key":"10.1016\/j.intimp.2026.116842_bb0260","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202302292","article-title":"High-throughput screening of surface engineered cyanine nanodots for active transport of therapeutic antibodies into solid tumor","volume":"36","author":"Qin","year":"2023","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb0265","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.nano.2014.09.006","article-title":"The development, characterization and in vivo anti-ovarian cancer activity of poly(propylene imine) (PPI)-antibody conjugates containing encapsulated paclitaxel","volume":"11","author":"Jain","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.intimp.2026.116842_bb0270","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.biomaterials.2014.12.030","article-title":"Reversal of p-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery","volume":"45","author":"JG, X., Hao J, Sha X.","year":"2015","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb0275","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1556-276X-9-247","article-title":"Dendrimers: synthesis, applications, and properties","volume":"9","author":"Abbasi","year":"2014","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.intimp.2026.116842_bb0280","doi-asserted-by":"crossref","unstructured":"Jain K, Kesharwani P, Gupta U, Jain NK. Dendrimer toxicity: let's meet the challenge. Int. J. Pharm. 2010;394(1-2):122-42.","DOI":"10.1016\/j.ijpharm.2010.04.027"},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb0285","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1039\/B901839P","article-title":"Biomedical applications of dendrimers: a tutorial","volume":"40","author":"Mintzer","year":"2011","journal-title":"Chem. Soc. Rev."},{"issue":"4","key":"10.1016\/j.intimp.2026.116842_bb0290","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1021\/acs.molpharmaceut.9b01280","article-title":"EGFR-targeted nanobody functionalized polymeric micelles loaded with mTHPC for selective photodynamic therapy","volume":"17","author":"Liu","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.intimp.2026.116842_bb0295","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jconrel.2021.02.031","article-title":"Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions","volume":"332","author":"Ghezzi","year":"2021","journal-title":"Journal of controlled release\u202f: official journal of the Controlled Release Society."},{"issue":"45","key":"10.1016\/j.intimp.2026.116842_bb0300","doi-asserted-by":"crossref","first-page":"15881","DOI":"10.1021\/ja106405c","article-title":"Targeting of cancer cells using click-functionalized polymer capsules","volume":"132","author":"Kamphuis","year":"2010","journal-title":"J. Am. Chem. Soc."},{"issue":"7","key":"10.1016\/j.intimp.2026.116842_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/polym15071808","article-title":"Ligand installation to polymeric micelles for pediatric brain tumor targeting","volume":"15","author":"Watanabe","year":"2023","journal-title":"Polymers"},{"issue":"7","key":"10.1016\/j.intimp.2026.116842_bb0310","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201906832","article-title":"Codelivery of anti-PD-1 antibody and paclitaxel with matrix metalloproteinase and pH dual-sensitive micelles for enhanced tumor chemoimmunotherapy","volume":"16","author":"Su","year":"2020","journal-title":"Small (Weinheim an der Bergstrasse, Germany)."},{"issue":"8","key":"10.1016\/j.intimp.2026.116842_bb0315","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.biomaterials.2009.11.067","article-title":"Anti-HIF-1\u03b1 antibody-conjugated pluronic triblock copolymers encapsulated with paclitaxel for tumor targeting therapy","volume":"31","author":"Hua","year":"2010","journal-title":"Biomaterials."},{"issue":"21","key":"10.1016\/j.intimp.2026.116842_bb0320","doi-asserted-by":"crossref","first-page":"5349","DOI":"10.1016\/j.biomaterials.2012.04.016","article-title":"Chemotherapy for gastric cancer by finely tailoring anti-Her2 anchored dual targeting immunomicelles","volume":"33","author":"Wei","year":"2012","journal-title":"Biomaterials."},{"key":"10.1016\/j.intimp.2026.116842_bb0325","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jconrel.2021.01.022","article-title":"Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo","volume":"331","author":"Andrade","year":"2021","journal-title":"Journal of controlled release\u202f: official journal of the Controlled Release Society."},{"issue":"10","key":"10.1016\/j.intimp.2026.116842_bb0330","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2217\/nnm-2019-0397","article-title":"Anti-PD-L1-modified and ATRA-loaded nanoparticles for immuno-treatment of oral dysplasia and oral squamous cell carcinoma","volume":"15","author":"Chen","year":"2020","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.intimp.2026.116842_bb0335","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2022.11.025","article-title":"PTN-PTPRZ1 signaling axis blocking mediates tumor microenvironment remodeling for enhanced glioblastoma treatment","volume":"353","author":"Yang","year":"2023","journal-title":"Journal of controlled release\u202f: official journal of the Controlled Release Society."},{"key":"10.1016\/j.intimp.2026.116842_bb0340","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jconrel.2025.01.022","article-title":"Multiple synergistic anti-aging effects of vascular cell adhesion molecule 1 functionalized nanoplatform to improve age-related neurodegenerative diseases","volume":"379","author":"Zhu","year":"2025","journal-title":"Journal of controlled release\u202f: official journal of the Controlled Release Society."},{"issue":"12","key":"10.1016\/j.intimp.2026.116842_bb0345","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202007798","article-title":"Targeted dual small interfering ribonucleic acid delivery via non-viral polymeric vectors for pulmonary fibrosis therapy","volume":"33","author":"Ji","year":"2021","journal-title":"Advanced materials (Deerfield Beach, Fla)."},{"key":"10.1016\/j.intimp.2026.116842_bb0350","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jconrel.2022.12.062","article-title":"Antibody-modified DNase i micelles specifically recognize the neutrophil extracellular traps (NETs) and promote their degradation","volume":"354","author":"Filipczak","year":"2023","journal-title":"Journal of controlled release\u202f: official journal of the Controlled Release Society."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb0355","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/s41467-024-44963-3","article-title":"Redox-responsive polymer micelles co-encapsulating immune checkpoint inhibitors and chemotherapeutic agents for glioblastoma therapy","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb0360","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12951-023-01772-y","article-title":"Peripheral administration of nanomicelle-encapsulated anti-a\u03b2 oligomer fragment antibody reduces various toxic a\u03b2 species in the brain","volume":"21","author":"Amano","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.intimp.2026.116842_bb0365","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.addr.2014.10.001","article-title":"The challenges facing block copolymer micelles for cancer therapy: In vivo barriers and clinical translation","volume":"91","author":"Eetezadi","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.intimp.2026.116842_bb0370","article-title":"Hydrogels based drug delivery synthesis","volume":"11","author":"Onaciu","year":"2019","journal-title":"Characterization and Administration. Pharmaceutics."},{"key":"10.1016\/j.intimp.2026.116842_bb0375","doi-asserted-by":"crossref","first-page":"2213867","DOI":"10.1002\/adfm.202213867","article-title":"Bioresponsive self-reinforcing Sericin\/silk fibroin hydrogel for relieving the immune-related adverse events in tumor immunotherapy","volume":"33","author":"Gou","year":"2023","journal-title":"Adv. Funct. Mater."},{"issue":"43","key":"10.1016\/j.intimp.2026.116842_bb0380","doi-asserted-by":"crossref","first-page":"10355","DOI":"10.1039\/D3TB01974H","article-title":"Engineered elastin-like polypeptide-based hydrogel delivering chemotherapeutics and PD-L1 antibodies for potentiated cancer immunotherapy","volume":"11","author":"Chen","year":"2023","journal-title":"J. Mater. Chem. B."},{"issue":"11","key":"10.1016\/j.intimp.2026.116842_bb0385","doi-asserted-by":"crossref","first-page":"10651","DOI":"10.1021\/acsnano.3c01748","article-title":"Supramolecular filament hydrogel as a universal immunomodulator carrier for immunotherapy combinations","volume":"17","author":"Wang","year":"2023","journal-title":"ACS Nano."},{"key":"10.1016\/j.intimp.2026.116842_bb0390","doi-asserted-by":"crossref","first-page":"2401581","DOI":"10.1002\/admt.202401581","article-title":"Development of a novel ultra-acidic self-assembling peptides-based hydrogel system for pH-tunable nanobody delivery","volume":"10","author":"Guo","year":"2024","journal-title":"Advanced Materials Technologies."},{"issue":"6","key":"10.1016\/j.intimp.2026.116842_bb0395","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202100049","article-title":"Design of an injectable polypeptide hydrogel depot containing the immune checkpoint blocker anti-PD-L1 and doxorubicin to enhance antitumor combination therapy","volume":"21","author":"Shi","year":"2021","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.intimp.2026.116842_bb0400","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/pol.20210955","article-title":"Enhanced antitumor chemo-immunotherapy by local co-delivery of chemotherapeutics, immune checkpoint blocking antibody and IDO inhibitor using an injectable polypeptide hydrogel","volume":"60","author":"Junfeng","year":"2022","journal-title":"J. Polym. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb0405","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1021\/acs.biomac.4c01296","article-title":"Nanofibrous peptide hydrogels leveraging histidine to modulate pH-responsive supramolecular assembly and antibody release","volume":"26","author":"Saenz","year":"2024","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.intimp.2026.116842_bb0410","doi-asserted-by":"crossref","first-page":"114691","DOI":"10.1016\/j.ejpb.2025.114691","article-title":"Peptide-based hydrogel co-assembled with antibody-drug for enhanced retinal cell uptake and attenuated experimental autoimmune uveitis","volume":"210","author":"Dai","year":"2025","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.intimp.2026.116842_bb0415","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.3390\/pharmaceutics15041264","article-title":"Peptide nanofiber system for sustained delivery of anti-VEGF proteins to the eye vitreous","volume":"15","author":"Yaylaci","year":"2023","journal-title":"Pharmaceutics."},{"issue":"13","key":"10.1016\/j.intimp.2026.116842_bb0420","doi-asserted-by":"crossref","DOI":"10.3390\/polym15132908","article-title":"A comprehensive review of polysaccharide-based hydrogels as promising biomaterials","volume":"15","author":"Berradi","year":"2023","journal-title":"Polymers"},{"issue":"23","key":"10.1016\/j.intimp.2026.116842_bb0425","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/marc.201600371","article-title":"Stimuli-sensitive injectable hydrogels based on polysaccharides and their biomedical applications","volume":"37","author":"Thambi","year":"2016","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.intimp.2026.116842_bb0430","first-page":"305","article-title":"Micro-ecology restoration of colonic inflammation by in-situ oral delivery of antibody-laden hydrogel microcapsules","volume":"15","author":"Li","year":"2021","journal-title":"Bioact. Mater."},{"issue":"15","key":"10.1016\/j.intimp.2026.116842_bb0435","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202370","article-title":"Crystalline antibody-laden alginate particles: a platform for enabling high concentration subcutaneous delivery of antibodies","volume":"12","author":"Erfani","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.intimp.2026.116842_bb0440","doi-asserted-by":"crossref","first-page":"106144","DOI":"10.1016\/j.jddst.2024.106144","article-title":"A thermosensitive hydrogel for the sustained delivery of exosomes extracted from menstrual blood mesenchymal stem cells and frizzled antibody on triple-negative breast cancer cells in vitro","volume":"101","author":"Hasannejad","year":"2024","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"13","key":"10.1016\/j.intimp.2026.116842_bb0445","article-title":"Subcutaneous administration of a zwitterionic chitosan-based hydrogel for controlled spatiotemporal release of monoclonal antibodies","volume":"36","author":"Gr\u00e9a","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.intimp.2026.116842_bb0450","article-title":"259 injectable chitosan hydrogel for localized delivery of immune checkpoint inhibitors. Journal for ImmunoTherapy of","volume":"9","author":"Mantooth","year":"2021","journal-title":"Cancer."},{"issue":"30","key":"10.1016\/j.intimp.2026.116842_bb0455","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202008054","article-title":"Hydrogel-induced cell membrane disruptions enable direct cytosolic delivery of membrane-impermeable cargo","volume":"33","author":"Van Hoeck","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.intimp.2026.116842_bb0460","doi-asserted-by":"crossref","first-page":"104993","DOI":"10.1016\/j.ejps.2019.104993","article-title":"In situ antibody-loaded hydrogel for intravitreal delivery","volume":"137","author":"Sahar","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"issue":"23","key":"10.1016\/j.intimp.2026.116842_bb0465","doi-asserted-by":"crossref","first-page":"6804","DOI":"10.1039\/D4TB02606C","article-title":"Iron(II)-catalysed tyrosinase crosslinked hyaluronic acid hydrogel for the controlled release of human antibodies","volume":"13","author":"Asamoah","year":"2025","journal-title":"J. Mater. Chem. B."},{"key":"10.1016\/j.intimp.2026.116842_bb0470","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.supflu.2017.04.006","article-title":"Preparation of barley and yeast \u03b2-glucan scaffolds by hydrogel foaming: evaluation of dexamethasone release","volume":"127","author":"Salgado","year":"2017","journal-title":"J. Supercrit. Fluids."},{"key":"10.1016\/j.intimp.2026.116842_bb0475","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.carbpol.2018.08.053","article-title":"\u0392-Glucan-based temperature responsive hydrogels for 5-ASA delivery","volume":"201","author":"Eyigor","year":"2018","journal-title":"Carbohydr. Polym."},{"issue":"20","key":"10.1016\/j.intimp.2026.116842_bb0480","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1039\/D2BM00935H","article-title":"A hybrid hydrogel composed of chitin and \u03b2-glucan for the effective management of wound healing and scarring","volume":"10","author":"Kang","year":"2022","journal-title":"Biomaterials Science."},{"key":"10.1016\/j.intimp.2026.116842_bb0485","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jconrel.2023.09.010","article-title":"An additive-free multifunctional \u03b2-glucan-peptide hydrogel participates in the whole process of bacterial-infected wound healing","volume":"362","author":"Li","year":"2023","journal-title":"J. Control. Release."},{"key":"10.1016\/j.intimp.2026.116842_bb0490","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jiec.2019.02.014","article-title":"\u0392-Glucan hybridized poly(ethylene glycol) microgels for macrophage-targeted protein delivery","volume":"75","author":"Tae","year":"2019","journal-title":"Journal of Industrial and Engineering Chemistry."},{"key":"10.1016\/j.intimp.2026.116842_bb0495","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bcdf.2015.09.005","article-title":"Barley \u03b2-glucan cryogels as encapsulation carriers of proteins: impact of molecular size on thermo-mechanical and release properties","volume":"6","author":"Lazaridou","year":"2015","journal-title":"Bioact. Carbohydr. Diet. Fibre."},{"issue":"11","key":"10.1016\/j.intimp.2026.116842_bb0500","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3109\/03639045.2011.650646","article-title":"Characterization and evaluation of \u03b2-glucan formulations as injectable implants for protein and peptide delivery","volume":"38","author":"Jacobs","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb0505","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1038\/s41467-022-32160-z","article-title":"Reactive oxygen species-responsive and raman-traceable hydrogel combining photodynamic and immune therapy for postsurgical cancer treatment","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116842_bb0510","doi-asserted-by":"crossref","first-page":"2000216","DOI":"10.1002\/adtp.202000216","article-title":"Hydrogel microsphere encapsulation enhances the flow properties of monoclonal antibody crystal formulations","volume":"4","author":"Jeremy","year":"2021","journal-title":"Advanced Therapeutics."},{"issue":"2","key":"10.1016\/j.intimp.2026.116842_bb0515","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202407239","article-title":"Sustained Endocytosis Inhibition Via Locally-Injected Drug-Eluting Hydrogel Improves ADCC-Mediated Antibody Therapy in Colorectal Cancer","volume":"12","author":"Wu","year":"2024","journal-title":"Advanced Science."},{"key":"10.1016\/j.intimp.2026.116842_bb0520","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2018.11.026","article-title":"Hydrogels with prolonged release of therapeutic antibody: block junction chemistry modification of \u2018ABA\u2019 copolymers provides superior anticancer efficacy","volume":"293","author":"Yang","year":"2019","journal-title":"Journal of controlled release\u202f: official journal of the Controlled Release Society."},{"key":"10.1016\/j.intimp.2026.116842_bb0525","doi-asserted-by":"crossref","first-page":"108104","DOI":"10.1016\/j.cclet.2022.108104","article-title":"Local sustained release of PD-1 monoclonal antibody and lenvatinib by thermo-sensitive hydrogel for improving tumor immunotherapy","volume":"34","author":"Zhengxi","year":"2023","journal-title":"Chin. Chem. Lett."},{"issue":"12","key":"10.1016\/j.intimp.2026.116842_bb0530","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1039\/D4BM00241E","article-title":"ROS-responsive thermosensitive polypeptide hydrogels for localized drug delivery and improved tumor chemoimmunotherapy","volume":"12","author":"Li","year":"2024","journal-title":"Biomaterials, Science."},{"issue":"9","key":"10.1016\/j.intimp.2026.116842_bb0535","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201701393","article-title":"Tough composite hydrogels with high loading and local release of biological drugs","volume":"7","author":"Li","year":"2018","journal-title":"Adv. Healthc. Mater."},{"issue":"38","key":"10.1016\/j.intimp.2026.116842_bb0540","doi-asserted-by":"crossref","first-page":"8830","DOI":"10.1039\/D0TB01360A","article-title":"Versatile composite hydrogels for drug delivery and beyond","volume":"8","author":"Chiang","year":"2020","journal-title":"J. Mater. Chem. B"},{"issue":"4","key":"10.1016\/j.intimp.2026.116842_bb0545","article-title":"Evolution of Hybrid Hydrogels: Next-Generation Biomaterials for Drug Delivery and Tissue Engineering","volume":"10","author":"Rana","year":"2024","journal-title":"Gels (Basel, Switzerland)"},{"key":"10.1016\/j.intimp.2026.116842_bb0550","doi-asserted-by":"crossref","DOI":"10.1007\/s13346-025-02033-1","article-title":"Clinical translation of injectable hydrogels: from bioactive polymers to long-acting drug delivery systems","author":"Carballo-Pedrares","year":"2026","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.intimp.2026.116842_bb0555","doi-asserted-by":"crossref","first-page":"114021","DOI":"10.1016\/j.jconrel.2025.114021","article-title":"Recent advances and challenges of injectable hydrogels in drug delivery","volume":"385","author":"Guo","year":"2025","journal-title":"J. Control. Release."},{"issue":"10","key":"10.1016\/j.intimp.2026.116842_bb0560","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16101306","article-title":"Biomimetic nanoparticles for basic drug delivery","volume":"16","author":"Tikhonov","year":"2024","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.intimp.2026.116842_bb0565","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s13346-022-01252-0","article-title":"Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system","volume":"13","author":"Liu","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"issue":"32","key":"10.1016\/j.intimp.2026.116842_bb0570","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202314197","article-title":"An engineered nanoplatform with tropism toward irradiated glioblastoma augments its radioimmunotherapy efficacy","volume":"36","author":"Wang","year":"2024","journal-title":"Advanced materials (Deerfield Beach, Fla)."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb0575","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41467-025-67698-1","article-title":"Antibody-conjugated mesenchymal stromal cell drug delivery system for the treatment of autoimmune diseases in mice","volume":"17","author":"Xie","year":"2026","journal-title":"Nat. Commun."},{"issue":"14","key":"10.1016\/j.intimp.2026.116842_bb0580","doi-asserted-by":"crossref","first-page":"10142","DOI":"10.1021\/acsnano.3c13088","article-title":"Brain delivery of biomimetic phosphorus dendrimer\/antibody nanocomplexes for enhanced glioma immunotherapy via immune modulation of t cells and natural killer cells","volume":"18","author":"Peng","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.intimp.2026.116842_bb0585","doi-asserted-by":"crossref","first-page":"8253","DOI":"10.2147\/IJN.S461212","article-title":"A biomimetic nanocarrier strategy targets ferroptosis and efferocytosis during myocardial infarction","volume":"19","author":"Song","year":"2024","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb0590","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12885-024-12006-1","article-title":"Inhibition of growth of hepatocellular carcinoma by co-delivery of anti-PD-1 antibody and sorafenib using biomimetic nano-platelets","volume":"24","author":"Xuanbo","year":"2024","journal-title":"BMC Cancer."},{"issue":"4","key":"10.1016\/j.intimp.2026.116842_bb0595","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe7174","article-title":"Sustained and targeted delivery of checkpoint inhibitors by metal-organic frameworks for cancer immunotherapy","volume":"7","author":"Alsaiari","year":"2021","journal-title":"Sci. Adv."},{"issue":"47","key":"10.1016\/j.intimp.2026.116842_bb0600","doi-asserted-by":"crossref","first-page":"20157","DOI":"10.1039\/D1NR06015E","article-title":"A biomimetic nanocomposite made of a ginger-derived exosome and an inorganic framework for high-performance delivery of oral antibodies","volume":"13","author":"Mao","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.intimp.2026.116842_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.124342","article-title":"Bionic lipoprotein loaded with chloroquine-mediated blocking immune escape improves antitumor immunotherapy","volume":"240","author":"Dong","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.intimp.2026.116842_bb0610","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.772522","article-title":"Research progress on cell membrane-coated biomimetic delivery systems","volume":"9","author":"Guo","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116842_bb0615","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.cell.2025.11.015","article-title":"Sensitized mast cells for targeted drug delivery and augmented cancer immunotherapy","volume":"189","author":"Xu","year":"2025","journal-title":"Cell."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb0620","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev-chembioeng-100722-121610","article-title":"Accelerating diverse cell-based therapies through scalable design","volume":"15","author":"Peterman","year":"2024","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"key":"10.1016\/j.intimp.2026.116842_bb0625","first-page":"135","article-title":"Designer mammalian living materials through genetic engineering","volume":"48","author":"Gameiro","year":"2025","journal-title":"Bioact. Mater."},{"issue":"4","key":"10.1016\/j.intimp.2026.116842_bb0630","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ccell.2020.07.005","article-title":"Engineering CAR-T cells for next-generation cancer therapy","volume":"38","author":"Hong","year":"2020","journal-title":"Cancer Cell."},{"issue":"16\u201317","key":"10.1016\/j.intimp.2026.116842_bb0635","first-page":"1157","article-title":"Construction and characterisation of a functional CD19 specific single chain fv fragment for immunotherapy of b lineage leukaemia and lymphoma","volume":"34","author":"Nicholson","year":"1998","journal-title":"Mol. Immunol."},{"issue":"18 Pt 1","key":"10.1016\/j.intimp.2026.116842_bb0640","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1158\/1078-0432.CCR-07-0674","article-title":"Genetically targeted t cells eradicate systemic acute lymphoblastic leukemia xenografts","volume":"13","author":"Brentjens","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.intimp.2026.116842_bb0645","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3390\/cancers12030567","article-title":"A preclinical embryonic zebrafish xenograft model to investigate CAR t cells in vivo","volume":"12","author":"Pascoal","year":"2020","journal-title":"Cancers."},{"issue":"14","key":"10.1016\/j.intimp.2026.116842_bb0650","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1056\/NEJMoa1914347","article-title":"KTE-X19 CAR T-cell therapy in relapsed or refractory mantle-cell lymphoma","volume":"382","author":"Wang","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.intimp.2026.116842_bb0655","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.intimp.2026.116842_bb0660","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S1470-2045(19)30493-0","article-title":"Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory b-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial","volume":"20","author":"Laetsch","year":"2019","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.intimp.2026.116842_bb0665","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.trecan.2025.08.014","article-title":"CAR t cell persistence in cancer","volume":"11","author":"Mueller","year":"2025","journal-title":"Trends in Cancer."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb0670","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1038\/s41467-020-16160-5","article-title":"Systematically optimized BCMA\/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma","volume":"11","author":"Zah","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116842_bb0675","author":"Phase"},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb0680","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/imr.12125","article-title":"Of CARs and TRUCKs: chimeric antigen receptor (CAR) t cells engineered with an inducible cytokine to modulate the tumor stroma","volume":"257","author":"Chmielewski","year":"2013","journal-title":"Immunol. Rev."},{"issue":"8","key":"10.1016\/j.intimp.2026.116842_bb0685","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/CJI.0b013e3181ee6675","article-title":"Enhanced tumor trafficking of GD2 chimeric antigen receptor t cells by expression of the chemokine receptor CCR2b","volume":"33","author":"Craddock","year":"2010","journal-title":"J. Immunother."},{"issue":"14","key":"10.1016\/j.intimp.2026.116842_bb0690","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1158\/1078-0432.CCR-11-0351","article-title":"Expression of a functional CCR2 receptor enhances tumor localization and tumor eradication by retargeted human t cells expressing a mesothelin-specific chimeric antibody receptor","volume":"17","author":"Moon","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.intimp.2026.116842_bb0695","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of t cell co-stimulation and co-inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2026.116842_bb0700","doi-asserted-by":"crossref","first-page":"e9158","DOI":"10.15252\/emmm.201809158","article-title":"In vivo generation of human CD19-CAR t cells results in b-cell depletion and signs of cytokine release syndrome","volume":"10","author":"Pfeiffer","year":"2018","journal-title":"EMBO Mol. Med."},{"issue":"10","key":"10.1016\/j.intimp.2026.116842_bb0705","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1016\/j.ymthe.2025.06.036","article-title":"Targeted in vivo delivery of genetic medicines utilizing an engineered lentiviral vector platform results in CAR t and NK cell generation","volume":"33","author":"Andorko","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.intimp.2026.116842_bb0715","doi-asserted-by":"crossref","DOI":"10.1126\/science.adz8994","article-title":"B lymphocyte protein factories produced by hematopoietic stem cell gene editing","author":"Hartweger","year":"2026","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.intimp.2026.116842_bb0720","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1182\/blood-2008-09-177139","article-title":"Engineering human hematopoietic stem\/progenitor cells to produce a broadly neutralizing anti-HIV antibody after in vitro maturation to human b lymphocytes","volume":"113","author":"Luo","year":"2009","journal-title":"Blood."},{"issue":"8","key":"10.1016\/j.intimp.2026.116842_bb0725","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/s41587-022-01328-9","article-title":"In vivo engineered b cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice","volume":"40","author":"Nahmad","year":"2022","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116842_bb0730","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymthe.2017.11.012","article-title":"Engineering protein-secreting plasma cells by homology-directed repair in primary human b cells","volume":"26","author":"Hung","year":"2017","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.intimp.2026.116842_bb0735","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/s41419-020-03187-1","article-title":"Engineering of \u03b1-PD-1 antibody-expressing long-lived plasma cells by CRISPR\/Cas9-mediated targeted gene integration","volume":"11","author":"Luo","year":"2020","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.intimp.2026.116842_bb0740","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.2174\/0113892010307146240626080746","article-title":"Cancer antibody engineering: comparison of mammalian, yeast, bacterial, plants, cell-free and hybridoma expression systems","volume":"26","author":"Ng","year":"2024","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.intimp.2026.116842_bb0745","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.biomaterials.2017.09.020","article-title":"Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery","volume":"147","author":"Parodi","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2026.116842_bb0750","doi-asserted-by":"crossref","first-page":"vi163","DOI":"10.1093\/neuonc\/noab196.641","article-title":"AAV mediated brain delivery of an adcc-enhanced antibody obviates xenograft growth in mouse models of HER2+ breast cancer brain metastasis","volume":"23","author":"Laks","year":"2021","journal-title":"Neuro-Oncology."},{"issue":"12_Supplement","key":"10.1016\/j.intimp.2026.116842_bb0755","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2022-LB201","article-title":"Abstract LB201: optimizing adeno-associated viral vector-mediated delivery of trastuzumab to the central nervous system for the treatment of her2 positive brain metastasis","volume":"82","author":"Werner","year":"2022","journal-title":"Cancer Res."},{"issue":"Pt 1","key":"10.1016\/j.intimp.2026.116842_bb0760","article-title":"IL-16 exerts anti-rabies virus effects through CD9 on the surface of viral particles","volume":"305","author":"Zhang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"104","key":"10.1016\/j.intimp.2026.116842_bb0765","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adq4973","article-title":"Adeno-associated viral delivery of env-specific antibodies prevents SIV rebound after discontinuing antiretroviral therapy","volume":"10","author":"Klenchin","year":"2025","journal-title":"Sci. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116842_bb0770","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.immuni.2019.02.005","article-title":"Adeno-associated virus delivery of anti-HIV monoclonal antibodies can drive Long-term virologic suppression","volume":"50","author":"Martinez-Navio","year":"2019","journal-title":"Immunity."},{"issue":"16","key":"10.1016\/j.intimp.2026.116842_bb0775","doi-asserted-by":"crossref","first-page":"8334","DOI":"10.1128\/JVI.00908-15","article-title":"Broadly neutralizing human immunodeficiency virus type 1 antibody gene transfer protects nonhuman primates from mucosal simian-human immunodeficiency virus infection","volume":"89","author":"Saunders","year":"2015","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116842_bb0780","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/s41591-022-01762-x","article-title":"Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial","volume":"28","author":"Casazza","year":"2022","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.intimp.2026.116842_bb0785","doi-asserted-by":"crossref","first-page":"101541","DOI":"10.1016\/j.omtm.2025.101541","article-title":"Development of VNX-101, an adeno-associated virus with less immunogenicity and efficient long-term expression of a CD19 t cell engager","volume":"33","author":"Currier","year":"2025","journal-title":"Molecular Therapy - Methods & Clinical Development."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101287","article-title":"The combination therapy of oncolytic HSV-1 armed with anti-PD-1 antibody and IL-12 enhances anti-tumor efficacy","volume":"15","author":"Xie","year":"2022","journal-title":"Transl. Oncol."},{"issue":"16_suppl","key":"10.1016\/j.intimp.2026.116842_bb0800","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1200\/JCO.2023.41.16_suppl.2520","article-title":"A phase 1\/2a study of T3011, an oncolytic HSV expressing IL-12 and PD-1 antibody, administered via intratumoral (IT) injection as monotherapy in advanced solid tumors","volume":"41","author":"Ji","year":"2023","journal-title":"J. Clinical Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb0805","first-page":"214","article-title":"Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1. Journal for ImmunoTherapy of","volume":"7","author":"Thomas","year":"2019","journal-title":"Cancer."},{"key":"10.1016\/j.intimp.2026.116842_bb0810","author":"Open-Label"},{"key":"10.1016\/j.intimp.2026.116842_bb0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103240","article-title":"Enhanced antitumor efficacy of a novel oncolytic vaccinia virus encoding a fully monoclonal antibody against t-cell immunoglobulin and ITIM domain (TIGIT)","volume":"64","author":"Zuo","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.intimp.2026.116842_bb0820","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbrc.2021.04.078","article-title":"An oncolytic vaccinia virus armed with anti-human-PD-1 antibody and anti-human-4-1BB antibody double genes for cancer-targeted therapy","volume":"559","author":"Shi","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2026.116842_bb0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.103980","article-title":"Nano based-oncolytic viruses for cancer therapy","volume":"185","author":"Ajam-Hosseini","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.intimp.2026.116842_bb0830","doi-asserted-by":"crossref","unstructured":"Pierce KM, Miklavcic WR, Cook KP, Hennen MS, Bayles KW, Hollingsworth MA, et al. The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors. Nanomaterials (Basel, Switzerland). 2021;vol. 11(11).","DOI":"10.3390\/nano11113018"},{"issue":"22","key":"10.1016\/j.intimp.2026.116842_bb0835","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28227679","article-title":"Joining forces: The Combined Application of Therapeutic Viruses and Nanomaterials in Cancer Therapy","volume":"28","author":"Li","year":"2023","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.intimp.2026.116842_bb0840","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jconrel.2024.01.020","article-title":"Bacteria-based drug delivery for treating non-oncological diseases","volume":"366","author":"Cao","year":"2024","journal-title":"Journal of controlled release\u202f: official journal of the Controlled Release Society."},{"issue":"42","key":"10.1016\/j.intimp.2026.116842_bb0845","doi-asserted-by":"crossref","first-page":"10072","DOI":"10.1039\/D3TB01805A","article-title":"Genetically engineered bacteria: a new frontier in targeted drug delivery","volume":"11","author":"Fooladi","year":"2023","journal-title":"J. Mater. Chem. B"},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb0850","first-page":"134","article-title":"A bacteria-based system expressing anti-TNF-\u03b1 nanobody for enhanced cancer immunotherapy. Signal transduction and targeted","volume":"8","author":"Liu","year":"2023","journal-title":"Therapy."},{"issue":"10","key":"10.1016\/j.intimp.2026.116842_bb0855","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1016\/j.apsb.2022.05.006","article-title":"Macrophage-mediated tumor-targeted delivery of engineered salmonella typhimurium VNP20009 in anti-PD1 therapy against melanoma","volume":"12","author":"Wu","year":"2022","journal-title":"Acta Pharmaceutica Sinica B."},{"issue":"29","key":"10.1016\/j.intimp.2026.116842_bb0860","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202301835","article-title":"Neutrophil-mediated tumor-targeting delivery system of oncolytic bacteria combined with ICB for melanoma lung metastasis therapy","volume":"10","author":"Liu","year":"2023","journal-title":"Advanced, Science."},{"issue":"5","key":"10.1016\/j.intimp.2026.116842_bb0865","doi-asserted-by":"crossref","first-page":"101513","DOI":"10.1016\/j.xcrm.2024.101513","article-title":"Sonogenetics-controlled synthetic designer cells for cancer therapy in tumor mouse models","volume":"5","author":"Gao","year":"2024","journal-title":"Cell Reports Medicine."},{"key":"10.1016\/j.intimp.2026.116842_bb0870","doi-asserted-by":"crossref","first-page":"159533","DOI":"10.1016\/j.cej.2025.159533","article-title":"Precision-engineered bacterial nanovectors for synergetic co-delivery to harness cellular senescence and immunomodulation for enhanced tumor eradication","volume":"505","author":"Ye","year":"2025","journal-title":"Chem. Eng. J."},{"issue":"13","key":"10.1016\/j.intimp.2026.116842_bb0875","doi-asserted-by":"crossref","first-page":"eadt7298","DOI":"10.1126\/sciadv.adt7298","article-title":"Programmable engineered bacteria as sustained-releasing antibody factory in situ for enhancing tumor immune checkpoint therapy","volume":"11","author":"Xie","year":"2025","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb0880","first-page":"226","article-title":"Engineered probiotic-mediated intratumoral delivery and controlled release of bacterial collagenase for cancer therapy, Synthetic and Systems","volume":"10","author":"Li","year":"2024","journal-title":"Biotechnology."},{"issue":"12","key":"10.1016\/j.intimp.2026.116842_bb0885","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1002\/bit.28829","article-title":"Sequential delivery of photosensitizers and checkpoint inhibitors by engineered bacteria for enhanced cancer photodynamic immunotherapy","volume":"121","author":"Liu","year":"2024","journal-title":"Biotechnol. Bioeng."},{"issue":"31","key":"10.1016\/j.intimp.2026.116842_bb0890","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202401905","article-title":"Nanobody-engineered biohybrid bacteria targeting gastrointestinal cancers induce robust STING-mediated anti-tumor immunity","volume":"11","author":"Xu","year":"2024","journal-title":"Advanced, Science."},{"issue":"5","key":"10.1016\/j.intimp.2026.116842_bb0895","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.3390\/ijms26052257","article-title":"Lactobacillus plantae expressing porcine reproductive and respiratory syndrome virus (PRRSV) single-chain antibody can inhibit PRRSV replication and change the intestinal flora structure of piglets","volume":"26","author":"Niu","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb0900","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/pharmaceutics15010063","article-title":"Lactobacilli as a vector for delivery of nanobodies against norovirus infection","volume":"15","author":"Yuki","year":"2022","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.intimp.2026.116842_bb0905","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114443","article-title":"Decorated bacteria and the application in drug delivery","volume":"188","author":"Wu","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.intimp.2026.116842_bb0910","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202210949","article-title":"Dressing bacteria with a hybrid immunoactive nanosurface to elicit dual anticancer and antiviral immunity","volume":"35","author":"Liu","year":"2022","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb0915","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1038\/s41467-024-48128-0","article-title":"Targeted delivery of the probiotic saccharomyces boulardii to the extracellular matrix enhances gut residence time and recovery in murine colitis","volume":"15","author":"Heavey","year":"2024","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.intimp.2026.116842_bb0920","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.medj.2024.02.012","article-title":"Nanodrug-bacteria conjugates-mediated oncogenic collagen depletion enhances immune checkpoint blockade therapy against pancreatic cancer","volume":"5","author":"Li","year":"2024","journal-title":"Med."},{"key":"10.1016\/j.intimp.2026.116842_bb0925","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.actbio.2022.05.016","article-title":"Nanodrug-loaded bifidobacterium bifidum conjugated with anti-death receptor antibody for tumor-targeted photodynamic and sonodynamic synergistic therapy","volume":"146","author":"Li","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.intimp.2026.116842_bb0930","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.120850","article-title":"Conductive bacterial cellulose: from drug delivery to flexible electronics","volume":"313","author":"Prilepskii","year":"2023","journal-title":"Carbohydr. Polym."},{"issue":"10","key":"10.1016\/j.intimp.2026.116842_bb0935","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.tibtech.2022.03.005","article-title":"The tremendous biomedical potential of bacterial extracellular vesicles","volume":"40","author":"Xie","year":"2022","journal-title":"Trends Biotechnol."},{"issue":"19","key":"10.1016\/j.intimp.2026.116842_bb0940","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202417920","article-title":"TREM2 scFv-engineering escherichia coli displaying modulation of macrophages to boost cancer radio-immunotherapy","volume":"37","author":"Wang","year":"2025","journal-title":"Adv. Mater."},{"issue":"4","key":"10.1016\/j.intimp.2026.116842_bb0945","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70069","article-title":"Nanobody engineered and photosensitiser loaded bacterial outer membrane vesicles potentiate antitumour immunity and immunotherapy","volume":"14","author":"Xia","year":"2025","journal-title":"J. Extracell. Vesicles."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb0950","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12951-023-02273-8","article-title":"Enhancing immune responses of ESC-based TAA cancer vaccines with a novel OMV delivery system","volume":"22","author":"Jin","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116842_bb0955","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70234","article-title":"Single-chain anti-IL-1\u03b2 antibody carried by outer membrane vesicles of bacteroides fragilis alleviates tubular inflammation in chronic kidney disease","volume":"15","author":"Li","year":"2026","journal-title":"J. Extracell. Vesicles."},{"key":"10.1016\/j.intimp.2026.116842_bb0960","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jconrel.2022.04.029","article-title":"(131)I-\u03b1PD-L1 immobilized by bacterial cellulose for enhanced radio-immunotherapy of cancer","volume":"346","author":"Qi","year":"2022","journal-title":"Journal of controlled release\u202f: official journal of the Controlled Release Society."},{"issue":"3","key":"10.1016\/j.intimp.2026.116842_bb0965","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.synbio.2021.09.001","article-title":"Bioengineering bacterial encapsulin nanocompartments as targeted drug delivery system","volume":"6","author":"Van de Steen","year":"2021","journal-title":"Synthetic and Systems Biotechnology."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb0970","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1186\/s12964-024-01874-6","article-title":"Cytosolic delivery of monobodies using the bacterial type III secretion system inhibits oncogenic BCR: ABL1 signaling","volume":"22","author":"Lebon","year":"2024","journal-title":"Cell communication and signaling\u202f: CCS."},{"issue":"19","key":"10.1016\/j.intimp.2026.116842_bb0975","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194945","article-title":"Recent advances in Bacteria-based cancer treatment","volume":"14","author":"Wei","year":"2022","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.intimp.2026.116842_bb0980","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s42247-021-00335-x","article-title":"Review on metal nanoparticles as nanocarriers: current challenges and perspectives in drug delivery systems","volume":"5","author":"Chandrakala","year":"2022","journal-title":"Emerg. Mater."},{"key":"10.1016\/j.intimp.2026.116842_bb0985","doi-asserted-by":"crossref","first-page":"120162","DOI":"10.1016\/j.ijpharm.2020.120162","article-title":"Microwave-triggered\/HSP-targeted gold nano-system for triple-negative breast cancer photothermal therapy","volume":"593","author":"Cheng","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.intimp.2026.116842_bb0990","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.2022.36.S1.R4959","article-title":"Gold nanoparticles as a drug delivery vehicle system against ErbB2+ breast cancer","volume":"36","author":"Kouneski","year":"2022","journal-title":"FASEB J."},{"issue":"26","key":"10.1016\/j.intimp.2026.116842_bb0995","doi-asserted-by":"crossref","first-page":"16131","DOI":"10.1039\/D1RA01093J","article-title":"Gold nanoparticles conjugated with anti-CD133 monoclonal antibody and 5-fluorouracil chemotherapeutic agent as nanocarriers for cancer cell targeting","volume":"11","author":"Mohd-Zahid","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.intimp.2026.116842_bb1000","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jiec.2023.06.036","article-title":"Aptamer-conjugated gold nanoparticles platform as the intracellular delivery of antibodies for cancer therapy","volume":"126","author":"Yeom","year":"2023","journal-title":"J. Ind. Eng. Chem."},{"issue":"58","key":"10.1016\/j.intimp.2026.116842_bb1005","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.18632\/oncotarget.27221","article-title":"Targeted photodynamic therapy treatment of in vitro a375 metastatic melanoma cells","volume":"10","author":"Naidoo","year":"2019","journal-title":"Oncotarget"},{"issue":"27","key":"10.1016\/j.intimp.2026.116842_bb1010","doi-asserted-by":"crossref","first-page":"19490","DOI":"10.1039\/D4RA03858D","article-title":"The phototoxic effect of a gold-antibody-based nanocarrier of phthalocyanine on melanoma monolayers and tumour spheroids","volume":"14","author":"Nkune","year":"2024","journal-title":"RSC Adv."},{"issue":"8","key":"10.1016\/j.intimp.2026.116842_bb1015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272396","article-title":"Targeted non AR mediated smart delivery of abiraterone to the prostate cancer","volume":"17","author":"Baker","year":"2022","journal-title":"PloS One."},{"key":"10.1016\/j.intimp.2026.116842_bb1020","article-title":"D2B antibody and its scFvD2B fragment in nanomedicine: promising tools in the theranostics of prostate cancer","volume":"12","author":"Nadim","year":"2021","journal-title":"Adv. Nat. Sci. Nanosci. Nanotechnol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116842_bb1025","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1021\/acs.molpharmaceut.0c00911","article-title":"Intranasal delivery of Temozolomide-conjugated gold nanoparticles functionalized with anti-EphA3 for glioblastoma targeting","volume":"18","author":"Wang","year":"2021","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.intimp.2026.116842_bb1030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/jnt3040012","article-title":"Antibody delivery into the brain by radiosensitizer nanoparticles for targeted glioblastoma therapy","volume":"3","author":"Gal","year":"2022","journal-title":"Journal of Nanotheranostics."},{"issue":"51","key":"10.1016\/j.intimp.2026.116842_bb1035","doi-asserted-by":"crossref","first-page":"59258","DOI":"10.1021\/acsami.3c16829","article-title":"Selective targeting of Nanobody-modified gold nanoparticles to distinct cell types","volume":"15","author":"Lee","year":"2023","journal-title":"ACS Appl. Mater. Interfaces."},{"issue":"5","key":"10.1016\/j.intimp.2026.116842_bb1040","doi-asserted-by":"crossref","first-page":"5460","DOI":"10.1021\/acsnano.4c13916","article-title":"Amyloid targeting-gold nanoparticles-assisted x-ray therapy rescues islet \u03b2-cells from amyloid fibrils and restores insulin homeostasis","volume":"19","author":"Forgham","year":"2025","journal-title":"ACS Nano."},{"key":"10.1016\/j.intimp.2026.116842_bb1045","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.actbio.2019.12.012","article-title":"Antibody-directed metal-organic framework nanoparticles for targeted drug delivery","volume":"103","author":"Cherkasov","year":"2020","journal-title":"Acta Biomater."},{"issue":"4","key":"10.1016\/j.intimp.2026.116842_bb1050","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1021\/bc049951i","article-title":"Toxicity of gold nanoparticles functionalized with cationic and anionic side chains","volume":"15","author":"Goodman","year":"2004","journal-title":"Bioconjug. Chem."},{"issue":"6","key":"10.1016\/j.intimp.2026.116842_bb1055","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1517\/17425241003777010","article-title":"Gold nanoparticles: opportunities and challenges in nanomedicine","volume":"7","author":"Arvizo","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.intimp.2026.116842_bb1060","doi-asserted-by":"crossref","first-page":"2000178","DOI":"10.1002\/adtp.202000178","article-title":"Intracellular antibody delivery mediated by lipids, polymers, and inorganic nanomaterials for therapeutic applications","volume":"3","author":"Li","year":"2020","journal-title":"Advanced Therapeutics."},{"key":"10.1016\/j.intimp.2026.116842_bb1065","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.990362","article-title":"Carbon nanomaterials for drug delivery and tissue engineering","volume":"10","author":"Zheng","year":"2022","journal-title":"Front. Chem."},{"issue":"13","key":"10.1016\/j.intimp.2026.116842_bb1070","doi-asserted-by":"crossref","first-page":"eade5321","DOI":"10.1126\/sciadv.ade5321","article-title":"Mechanical nanosurgery of chemoresistant glioblastoma using magnetically controlled carbon nanotubes","volume":"9","author":"Wang","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.intimp.2026.116842_bb1075","first-page":"906","article-title":"K.P H, null n., HCT116 cells cytotoxic response to multifuctionalized 5- fluorouracil MWCNTs conjugates in colorectal cancer","volume":"4","year":"2021","journal-title":"International Journal of Current Science Research and Review."},{"issue":"10","key":"10.1016\/j.intimp.2026.116842_bb1080","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nnano.2013.194","article-title":"Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets","volume":"8","author":"Yoon","year":"2013","journal-title":"Nat. Nanotechnol."},{"issue":"33","key":"10.1016\/j.intimp.2026.116842_bb1085","doi-asserted-by":"crossref","first-page":"10876","DOI":"10.1021\/ja803688x","article-title":"PEGylated nanographene oxide for delivery of water-insoluble cancer drugs","volume":"130","author":"Liu","year":"2008","journal-title":"J. Am. Chem. Soc."},{"issue":"9","key":"10.1016\/j.intimp.2026.116842_bb1090","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1021\/nl100996u","article-title":"Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy","volume":"10","author":"Yang","year":"2010","journal-title":"Nano Lett."},{"issue":"43","key":"10.1016\/j.intimp.2026.116842_bb1095","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1002\/adma.201502615","article-title":"Antibody-modified reduced graphene oxide films with extreme sensitivity to circulating tumor cells","volume":"27","author":"Yingying","year":"2015","journal-title":"Adv. Mater."},{"issue":"5","key":"10.1016\/j.intimp.2026.116842_bb1100","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ajps.2021.04.002","article-title":"Anti-EpCAM functionalized graphene oxide vector for tumor targeted siRNA delivery and cancer therapy","volume":"16","author":"Chen","year":"2021","journal-title":"Asian journal of pharmaceutical sciences."},{"key":"10.1016\/j.intimp.2026.116842_bb1105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.carbon.2016.05.054","article-title":"Prostate cancer targeted multifunctionalized graphene oxide for magnetic resonance imaging and drug delivery","volume":"107","author":"Linlin","year":"2016","journal-title":"Carbon."},{"issue":"5","key":"10.1016\/j.intimp.2026.116842_bb1110","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1021\/acsbiomaterials.8b01628","article-title":"Single-layer assembly of multifunctional carboxymethylcellulose on graphene oxide nanoparticles for improving in vivo curcumin delivery into tumor cells","volume":"5","author":"Sahne","year":"2019","journal-title":"ACS Biomater Sci. Eng."},{"key":"10.1016\/j.intimp.2026.116842_bb1115","doi-asserted-by":"crossref","unstructured":"Lu YJ, Lin PY, Huang PH, Kuo CY, Shalumon KT, Chen MY, et al. Magnetic Graphene Oxide for Dual Targeted Delivery of Doxorubicin and Photothermal Therapy. Nanomaterials (Basel, Switzerland). 2018;vol. 8(4).","DOI":"10.3390\/nano8040193"},{"issue":"22","key":"10.1016\/j.intimp.2026.116842_bb1120","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.1039\/D1AN01237A","article-title":"Dual-targeting SERS-encoded graphene oxide nanocarrier for intracellular co-delivery of doxorubicin and 9-aminoacridine with enhanced combination therapy","volume":"146","author":"Chen","year":"2021","journal-title":"Analyst"},{"issue":"10","key":"10.1016\/j.intimp.2026.116842_bb1125","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1039\/C4NR07682F","article-title":"Nanocarriers in therapy of infectious and inflammatory diseases","volume":"7","author":"Ikoba","year":"2015","journal-title":"Nanoscale"},{"issue":"7","key":"10.1016\/j.intimp.2026.116842_bb1130","first-page":"2158","article-title":"Antibody-activated trans-endothelial delivery of mesoporous organosilica nanomedicine augments tumor extravasation and anti-cancer immunotherapy","volume":"6","author":"Huang","year":"2021","journal-title":"Bioact. Mater."},{"issue":"5","key":"10.1016\/j.intimp.2026.116842_bb1135","doi-asserted-by":"crossref","first-page":"7395","DOI":"10.1021\/acsami.4c19425","article-title":"Programmable porous silicon microparticles for temporally staged drug delivery in combination cancer immunotherapy","volume":"17","author":"Jeong","year":"2025","journal-title":"ACS Appl. Mater. Interfaces."},{"issue":"41","key":"10.1016\/j.intimp.2026.116842_bb1140","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1002\/anie.201705578","article-title":"Intracellular delivery of functional native antibodies under hypoxic conditions by using a biodegradable silica nanoquencher","volume":"56","author":"Yuan","year":"2017","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.intimp.2026.116842_bb1145","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122000","article-title":"Biodegradable silica nanocapsules enable efficient nuclear-targeted delivery of native proteins for cancer therapy","volume":"294","author":"Du","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2026.116842_bb1150","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121376","article-title":"Intracellular co-delivery of native antibody and siRNA for combination therapy by using biodegradable silica nanocapsules","volume":"281","author":"Yuan","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2026.116842_bb1155","doi-asserted-by":"crossref","first-page":"9845459","DOI":"10.34133\/2022\/9845459","article-title":"Platelet membrane-coated nanocarriers targeting plaques to deliver anti-CD47 antibody for atherosclerotic therapy","volume":"2022","author":"Chen","year":"2022","journal-title":"Research."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb1160","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12885-024-12006-1","article-title":"Inhibition of growth of hepatocellular carcinoma by co-delivery of anti-PD-1 antibody and sorafenib using biomimetic nano-platelets","volume":"24","author":"Da","year":"2024","journal-title":"BMC Cancer."},{"key":"10.1016\/j.intimp.2026.116842_bb1165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120677","article-title":"Targeting and clearance of senescent foamy macrophages and senescent endothelial cells by antibody-functionalized mesoporous silica nanoparticles for alleviating aorta atherosclerosis","volume":"269","author":"Pham","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2026.116842_bb1170","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112697","article-title":"Efficient delivery of abciximab using mesoporous silica nanoparticles: In-vitro assessment for targeted and improved antithrombotic activity","volume":"218","author":"Priya","year":"2022","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"4","key":"10.1016\/j.intimp.2026.116842_bb1175","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1007\/s00210-024-03536-3","article-title":"A promise of nose to brain delivery of bevacizumab intranasal sol-gel formulation substantiated in rat c6 glioma model","volume":"398","author":"Desai","year":"2024","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116842_bb1180","doi-asserted-by":"crossref","first-page":"124074","DOI":"10.1016\/j.ijpharm.2024.124074","article-title":"A novel FK506-loading mesoporous silica nanoparticle homing to lymph nodes for transplant rejection treatment","volume":"656","author":"Yishu","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"15","key":"10.1016\/j.intimp.2026.116842_bb1185","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.7150\/thno.76574","article-title":"Dual-targeted magnetic mesoporous silica nanoparticles reduce brain amyloid-\u03b2 burden via depolymerization and intestinal metabolism","volume":"12","author":"Liu","year":"2022","journal-title":"Theranostics."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb1190","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12951-024-02543-z","article-title":"A\u03b242 and ROS dual-targeted multifunctional nanocomposite for combination therapy of alzheimer\u2019s disease","volume":"22","author":"Zhang","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"19","key":"10.1016\/j.intimp.2026.116842_bb1195","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1016\/j.biomaterials.2009.02.029","article-title":"Calcium phosphate nanoparticles as efficient carriers for photodynamic therapy against cells and bacteria","volume":"30","author":"Schwiertz","year":"2009","journal-title":"Biomaterials."},{"key":"10.1016\/j.intimp.2026.116842_bb1200","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.actbio.2021.01.045","article-title":"Delivery of toll-like receptor 3 ligand poly(I: C) to the liver by calcium phosphate nanoparticles conjugated with an f4\/80 antibody exerts an anti-hepatitis b virus effect in a mouse model","volume":"133","author":"Du","year":"2021","journal-title":"Acta Biomater."},{"issue":"13","key":"10.1016\/j.intimp.2026.116842_bb1205","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e33837","article-title":"CaCO3-encapsulated polydopamine with an adsorbed TLR7 agonist for improved tumor photothermal immunotherapy","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon."},{"key":"10.1016\/j.intimp.2026.116842_bb1210","doi-asserted-by":"crossref","first-page":"102383","DOI":"10.1016\/j.nano.2021.102383","article-title":"Preferential uptake of antibody targeted calcium phosphosilicate nanoparticles by metastatic triple negative breast cancer cells in co-cultures of human metastatic breast cancer cells plus bone osteoblasts","volume":"34","author":"Bussard","year":"2021","journal-title":"Nanomedicine."},{"issue":"13","key":"10.1016\/j.intimp.2026.116842_bb1215","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1021\/acs.accounts.3c00122","article-title":"Surface engineering of nanoparticles toward cancer theranostics","volume":"56","author":"Huang","year":"2023","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.intimp.2026.116842_bb1220","doi-asserted-by":"crossref","first-page":"114044","DOI":"10.1016\/j.addr.2021.114044","article-title":"Cell-penetrating peptides in protein mimicry and cancer therapeutics","volume":"180","author":"Zorko","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.intimp.2026.116842_bb1225","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jbiomech.2018.03.036","article-title":"Cell penetrating peptide modulation of membrane biomechanics by molecular dynamics","volume":"73","author":"Grasso","year":"2018","journal-title":"J. Biomech."},{"issue":"9","key":"10.1016\/j.intimp.2026.116842_bb1230","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1007\/s00253-018-8889-5","article-title":"Elementary processes for the entry of cell-penetrating peptides into lipid bilayer vesicles and bacterial cells","volume":"102","author":"Islam","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116842_bb1235","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1074\/jbc.M805550200","article-title":"Cell entry of arginine-rich peptides is independent of endocytosis","volume":"284","author":"Ter-Avetisyan","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.intimp.2026.116842_bb1240","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41557-021-00661-x","article-title":"Cellular uptake of large biomolecules enabled by cell-surface-reactive cell-penetrating peptide additives","volume":"13","author":"Schneider","year":"2021","journal-title":"Nat. Chem."},{"key":"10.1016\/j.intimp.2026.116842_bb1245","doi-asserted-by":"crossref","DOI":"10.1021\/jacs.3c05365","article-title":"Cell-surface-retained peptide additives for the cytosolic delivery of functional proteins","author":"Arafiles","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"11","key":"10.1016\/j.intimp.2026.116842_bb1250","article-title":"Photoactivatable nanobody conjugate dimerizer temporally resolves Tiam1-Rac1 signaling axis","volume":"11","author":"Zhou","year":"2024","journal-title":"Advanced, Science."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb1255","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1021\/acs.biomac.1c00929","article-title":"Protein binding and release by polymeric cell-penetrating peptide mimics","volume":"23","author":"Davis","year":"2021","journal-title":"Biomacromolecules."},{"issue":"41","key":"10.1016\/j.intimp.2026.116842_bb1260","doi-asserted-by":"crossref","first-page":"47855","DOI":"10.1021\/acsami.3c01650","article-title":"Inkjet-based intracellular delivery system that effectively utilizes cell-penetrating peptides for cytosolic introduction of biomacromolecules through the cell membrane","volume":"15","author":"Omura","year":"2023","journal-title":"ACS Appl. Mater. Interfaces."},{"key":"10.1016\/j.intimp.2026.116842_bb1265","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1146\/annurev.biochem.78.081307.110540","article-title":"Mechanisms of endocytosis","volume":"78","author":"Doherty","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.intimp.2026.116842_bb1270","doi-asserted-by":"crossref","first-page":"114044","DOI":"10.1016\/j.addr.2021.114044","article-title":"Cell-penetrating peptides in protein mimicry and cancer therapeutics","volume":"180","author":"Matja\u017e","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2026.116842_bb1275","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41557-021-00866-0","article-title":"Tricyclic cell-penetrating peptides for efficient delivery of functional antibodies into cancer cells","volume":"14","author":"Ole","year":"2022","journal-title":"Nat. Chem."},{"issue":"10","key":"10.1016\/j.intimp.2026.116842_bb1280","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1016\/j.apsb.2024.06.022","article-title":"Charge-guided masking of a membrane-destabilizing peptide enables efficient endosomal escape for targeted intracellular delivery of proteins","volume":"14","author":"Zhao","year":"2024","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.intimp.2026.116842_bb1285","doi-asserted-by":"crossref","unstructured":"C. Seung-Eun, O. Jin-Seok, M. Kyoung-Wook, P. Sohyun, C. Su-Jung, A. Joon Hyung, et al., Intracellular delivery of immunoglobulin g at nanomolar concentrations with domain z-fused multimeric \u03b1-helical cell penetrating peptides, J. Control. Release. 330 (2021) 161-172.","DOI":"10.1016\/j.jconrel.2020.12.020"},{"issue":"8","key":"10.1016\/j.intimp.2026.116842_bb1290","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1021\/acs.bioconjchem.2c00152","article-title":"Cell penetrating peptides conjugated to anti-carcinoembryonic antigen \u201ccatch-and-release\u201d monoclonal antibodies alter plasma and tissue pharmacokinetics in colorectal cancer xenograft mice","volume":"33","author":"Polli","year":"2022","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.intimp.2026.116842_bb1295","doi-asserted-by":"crossref","first-page":"117835","DOI":"10.1016\/j.bmc.2024.117835","article-title":"An approach for the intracellular delivery of IgG via enzymatic ligation with a cell-permeable attenuated cationic amphiphilic lytic peptide","volume":"111","author":"Kawaguchi","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.intimp.2026.116842_bb1300","doi-asserted-by":"crossref","first-page":"150586","DOI":"10.1016\/j.bbrc.2024.150586","article-title":"Inhibition of enhanced green fluorescent protein cytosolic delivery mediated by modified cell-penetrating peptide due to high overexpression of caveolin-1","volume":"733","author":"Okuda","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.intimp.2026.116842_bb1305","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbapap.2021.140604","article-title":"Challenge to overcome current limitations of cell-penetrating peptides","volume":"1869","author":"Kim","year":"2021","journal-title":"Biochim. Biophys. Acta Proteins Proteomics"},{"issue":"5","key":"10.1016\/j.intimp.2026.116842_bb1310","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2174\/1381612823666170728094922","article-title":"Current delivery strategies to improve the target of cell penetrating peptides used for tumor-related therapeutics","volume":"24","author":"Zhang","year":"2018","journal-title":"Curr. Pharm. Des."},{"issue":"5","key":"10.1016\/j.intimp.2026.116842_bb1315","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14050907","article-title":"Redesigning of cell-penetrating peptides to improve their efficacy as a drug delivery system","volume":"14","author":"Szab\u00f3","year":"2022","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.intimp.2026.116842_bb1320","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.matt.2022.03.001","article-title":"Injectable liposome-based supramolecular hydrogels for the programmable release of multiple protein drugs","volume":"5","author":"Correa","year":"2022","journal-title":"Matter."},{"key":"10.1016\/j.intimp.2026.116842_bb1325","doi-asserted-by":"crossref","first-page":"108616","DOI":"10.1016\/j.cclet.2023.108616","article-title":"Photo-manipulated polyunsaturated fatty acid-doped liposomal hydrogel for flexible photoimmunotherapy","volume":"35","author":"Lan","year":"2023","journal-title":"Chin. Chem. Lett."},{"issue":"9","key":"10.1016\/j.intimp.2026.116842_bb1330","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/jps.24310","article-title":"Efficient and high-speed transduction of an antibody into living cells using a multifunctional nanocarrier system to control intracellular trafficking","volume":"104","author":"Yamada","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.intimp.2026.116842_bb1335","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.559596","article-title":"Biotherapeutic antibodies for the treatment of head and neck cancer: current approaches and future considerations of photothermal therapies","volume":"10","author":"Al Qaraghuli","year":"2020","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.intimp.2026.116842_bb1340","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1007\/s10147-021-01960-6","article-title":"A phase i, single-center, open-label study of RM-1929 photoimmunotherapy in japanese patients with recurrent head and neck squamous cell carcinoma","volume":"26","author":"Tahara","year":"2021","journal-title":"Int. J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116842_bb1345","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41418-025-01582-9","article-title":"TRIM24-mediated k27-linked ubiquitination of ULK1 alleviates energy stress-induced autophagy and promote prostate cancer growth in the context of SPOP mutation","volume":"33","author":"Chen","year":"2025","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.intimp.2026.116842_bb1350","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.exphem.2015.12.011","article-title":"Combination epigenetic and immunotherapy overcomes resistance to monoclonal antibodies in hematologic malignancies: a new therapeutic approach","volume":"44","author":"Epner","year":"2016","journal-title":"Exp. Hematol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116842_bb1355","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9030675","article-title":"Combining immune checkpoint inhibitors with anti-Angiogenic agents","volume":"9","author":"Ciciola","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2026.116842_bb1360","doi-asserted-by":"crossref","first-page":"123990","DOI":"10.1016\/j.ijpharm.2024.123990","article-title":"Enhancing precision medicine: bispecific antibody-mediated targeted delivery of lipid nanoparticles for potential cancer therapy","volume":"654","author":"Zhang","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.intimp.2026.116842_bb1365","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.2147\/IJN.S289228","article-title":"EGFR targeted Cetuximab-valine-Citrulline (vc)-doxorubicin immunoconjugates- loaded bovine serum albumin (BSA) nanoparticles for colorectal tumor therapy","volume":"16","author":"Ye","year":"2021","journal-title":"Int. J. Nanomedicine."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb1370","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1039\/D2BM01252A","article-title":"Pharmaceutical liposomal delivery\u2014specific considerations of innovation and challenges","volume":"11","author":"Peng","year":"2022","journal-title":"Biomaterials, Science."},{"issue":"3","key":"10.1016\/j.intimp.2026.116842_bb1375","doi-asserted-by":"crossref","first-page":"447","DOI":"10.17219\/acem\/186846","article-title":"Advantages and limitations of nanostructures for biomedical applications","volume":"34","author":"Roszkowski","year":"2025","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.intimp.2026.116842_bb1380","first-page":"128331","article-title":"Advances in liposome technology: An intensive review of formulation, therapeutic applications, and challenges","volume":"295","author":"Rajendiran","year":"2025","journal-title":"Curr. Enzym. Inhib."},{"key":"10.1016\/j.intimp.2026.116842_bb1385","volume":"9(3):56","author":"Basak","year":"2025","journal-title":"Liposome-Based Drug Delivery Systems: From Laboratory Research to Industrial Production\u2014Instruments and Challenges."},{"issue":"40","key":"10.1016\/j.intimp.2026.116842_bb1390","doi-asserted-by":"crossref","first-page":"47582","DOI":"10.1021\/acsomega.5c07827","article-title":"Global Characterization of Commercial Generation 0\u20137 Poly(Amidoamine) Dendrimers: Challenges and Opportunities for Analysis","volume":"10","author":"Tooley","year":"2025","journal-title":"ACS Omega."},{"key":"10.1016\/j.intimp.2026.116842_bb1395","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.addr.2017.11.007","article-title":"Bench-to-Bedside Translation of Dendrimers: Reality or Utopia? A concise analysis","volume":"136-137","author":"Mignani","year":"2017","journal-title":"Adv. Drug Delivery Rev."},{"issue":"6","key":"10.1016\/j.intimp.2026.116842_bb1400","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3390\/pharmaceutics14061292","article-title":"Safety challenges and application strategies for the use of dendrimers in medicine","volume":"14","author":"Li","year":"2022","journal-title":"Pharmaceutics."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb1405","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/14686996.2019.1590126","article-title":"Toxicity and immunogenicity concerns related to PEGylated-micelle carrier systems: a review","volume":"20","author":"Shiraishi","year":"2019","journal-title":"Sci. Technol. Adv. Mater."},{"issue":"8","key":"10.1016\/j.intimp.2026.116842_bb1410","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3390\/pharmaceutics16081047","article-title":"Functionalized polymeric micelles for targeted cancer therapy: steps from conceptualization to clinical trials","volume":"16","author":"Serras","year":"2024","journal-title":"Pharmaceutics."},{"issue":"10","key":"10.1016\/j.intimp.2026.116842_bb1415","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3390\/pharmaceutics17101360","article-title":"From conventional to next-generation strategies: recent advances in polymeric micelle preparation for drug delivery","volume":"17","author":"Cho","year":"2025","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.intimp.2026.116842_bb1420","doi-asserted-by":"crossref","first-page":"214471","DOI":"10.1016\/j.bioadv.2025.214471","article-title":"Cell membrane-engineered nanoparticles: a bionic platform for targeted cancer therapy","volume":"178","author":"Rafiya","year":"2025","journal-title":"Biomaterials Advances"},{"key":"10.1016\/j.intimp.2026.116842_bb1425","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s40843-025-3740-y","article-title":"Engineering revolution of cell membrane-biomimetic nanoparticles: from hybridization strategy innovation to microfluidics-enabled precision fabrication","volume":"69","author":"Liu","year":"2026","journal-title":"Sci. China-Mater."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb1430","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s40259-025-00753-x","article-title":"Cell engineering for increasing production of recombinant proteins in mammalian cells","volume":"40","author":"Zhang","year":"2025","journal-title":"BioDrugs\u202f: clinical immunotherapeutics, biopharmaceuticals and gene therapy."},{"issue":"9","key":"10.1016\/j.intimp.2026.116842_bb1435","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1002\/bit.28365","article-title":"Cell factory engineering: challenges and opportunities for synthetic biology applications","volume":"120","author":"Bachhav","year":"2023","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.intimp.2026.116842_bb1440","doi-asserted-by":"crossref","first-page":"107552","DOI":"10.1016\/j.biotechadv.2020.107552","article-title":"Mammalian cell culture for production of recombinant proteins: a review of the critical steps in their biomanufacturing","volume":"43","author":"O\u2019Flaherty","year":"2020","journal-title":"Biotechnol. Adv."},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb1445","first-page":"78","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal transduction and targeted","volume":"9","author":"Wang","year":"2024","journal-title":"Therapy."},{"issue":"2","key":"10.1016\/j.intimp.2026.116842_bb1450","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tim.2022.09.003","article-title":"Modes of therapeutic delivery in synthetic microbiology","volume":"31","author":"Alexander","year":"2022","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.intimp.2026.116842_bb1455","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jconrel.2023.07.056","article-title":"Designs of metal-organic framework nanoparticles for protein delivery","volume":"361","author":"Kai","year":"2023","journal-title":"J. Control. Release."},{"key":"10.1016\/j.intimp.2026.116842_bb1460","doi-asserted-by":"crossref","DOI":"10.1016\/j.hybadv.2025.100586","article-title":"From surface chemistry to nuclear targeting: the multifaceted challenge of genetic delivery via inorganic nanoparticles","volume":"12","author":"Vasti","year":"2026","journal-title":"Hybrid Advances."},{"issue":"7","key":"10.1016\/j.intimp.2026.116842_bb1465","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.2174\/0109298673278936240107121907","article-title":"Cell-penetrating peptides as keys to endosomal escape and intracellular trafficking in nanomedicine delivery","volume":"32","author":"Soni","year":"2024","journal-title":"Curr. Med. Chem."},{"issue":"11","key":"10.1016\/j.intimp.2026.116842_bb1470","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3390\/ph5111177","article-title":"Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges","volume":"5","author":"Erazo-Oliveras","year":"2012","journal-title":"Pharmaceuticals."},{"key":"10.1016\/j.intimp.2026.116842_bb1475","doi-asserted-by":"crossref","unstructured":"S. Liang, L. Xiao, T. Chen, P. Roa, E. Cocco, Z. Peng, et al., Injectable nanocomposite hydrogels improve intraperitoneal co-delivery of chemotherapeutics and immune checkpoint inhibitors for enhanced peritoneal metastasis therapy, ACS Nano. 18 (29) (2024) 18963-18979.","DOI":"10.1021\/acsnano.4c02312"},{"issue":"1","key":"10.1016\/j.intimp.2026.116842_bb1480","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/s41467-022-29121-x","article-title":"Thermosensitive hydrogel releasing nitric oxide donor and anti-CTLA-4 micelles for anti-tumor immunotherapy","volume":"13","author":"Kim","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116842_bb1485","doi-asserted-by":"crossref","first-page":"122714","DOI":"10.1016\/j.biomaterials.2024.122714","article-title":"Bioactive nanocomposite hydrogel enhances postoperative immunotherapy and bone reconstruction for osteosarcoma treatment","volume":"312","author":"Chu","year":"2024","journal-title":"Biomaterials."},{"key":"10.1016\/j.intimp.2026.116842_bb1490","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jconrel.2024.11.011","article-title":"Strategic delivery of rapamycin and ranibizumab with intravitreal hydrogel depot disrupts multipathway-driven angiogenesis loop for boosted wAMD therapy","volume":"377","author":"Jiang","year":"2024","journal-title":"J. Control. Release."},{"issue":"7","key":"10.1016\/j.intimp.2026.116842_bb1495","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1021\/acs.biomac.2c00383","article-title":"Hyaluronic Acid-PEG-Based Diels\u2013Alder In Situ Forming Hydrogels for Sustained Intraocular Delivery of Bevacizumab","volume":"23","author":"Ilochonwu","year":"2022","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.intimp.2026.116842_bb1500","doi-asserted-by":"crossref","DOI":"10.3390\/app11031164","article-title":"Ca-alginate-PEGMA hydrogels for in situ delivery of TGF-\u03b2 neutralizing antibodies in a mouse model of wound healing","volume":"11","author":"Gasperin-Bulbarela","year":"2021","journal-title":"Appl. Sci."},{"key":"10.1016\/j.intimp.2026.116842_bb1505","first-page":"1","article-title":"Alum-tuned hyaluronic acid-based hydrogel with immune checkpoint inhibition for immunophoto therapy of cancer","volume":"362","author":"Sungyun","year":"2023","journal-title":"J. Control. Release."},{"key":"10.1016\/j.intimp.2026.116842_bb1510","doi-asserted-by":"crossref","first-page":"9792","DOI":"10.1007\/s12274-023-5648-4","article-title":"Papillary fibroblast-recruiting injectable self-healing multifunctional hydrogels for wound regeneration","volume":"16","author":"Li","year":"2023","journal-title":"Nano Res."},{"key":"10.1016\/j.intimp.2026.116842_bb1515","doi-asserted-by":"crossref","first-page":"125952","DOI":"10.1016\/j.ijbiomac.2023.125952","article-title":"Oral colon-targeted responsive alginate\/hyaluronic acid-based hydrogel propels the application of infliximab in colitis","volume":"249","author":"Huai","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.intimp.2026.116842_bb1520","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jconrel.2023.07.052","article-title":"Thermo-responsive Diels-Alder stabilized hydrogels for ocular drug delivery of a corticosteroid and an anti-VEGF fab fragment","volume":"361","author":"Ilochonwu","year":"2023","journal-title":"J. Control. Release."},{"key":"10.1016\/j.intimp.2026.116842_bb1525","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121166","article-title":"In situ subcutaneously injectable thermosensitive PEG-PLGA diblock and PLGA-PEG-PLGA triblock copolymer composite as sustained delivery of bispecific anti-CD3 scFv T-cell\/anti-EGFR fab engager (BiTEE)","volume":"278","author":"Wei","year":"2021","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.intimp.2026.116842_bb1530","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/nano11020471","article-title":"In situ crosslinked hydrogel depot for sustained antibody release improves immune checkpoint blockade cancer immunotherapy","volume":"11","author":"Jihoon","year":"2021","journal-title":"Nanomaterials."},{"issue":"6","key":"10.1016\/j.intimp.2026.116842_bb1535","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1039\/D2BM00819J","article-title":"Subcutaneous delivery of an antibody against SARS-CoV-2 from a supramolecular hydrogel depot","volume":"11","author":"Catherine","year":"2023","journal-title":"Biomaterials, Science."},{"key":"10.1016\/j.intimp.2026.116842_bb1540","series-title":"An Injectable Hydrogel to Modulate T Cells for Cancer Immunotherapy","author":"Di","year":"2022"},{"key":"10.1016\/j.intimp.2026.116842_bb1545","doi-asserted-by":"crossref","first-page":"e1148","DOI":"10.1002\/smm2.1148","article-title":"Injectable \u201ccocktail\u201d hydrogel with dual-stimuli-responsive drug release, photothermal ablation, and drug-antibody synergistic effect","volume":"5","author":"Zhao","year":"2022","journal-title":"SmartMat."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926006880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926006880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:04:56Z","timestamp":1789243496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926006880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":306,"alternative-id":["S1567576926006880"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116842","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced platforms for antibody delivery: Overcoming biological barriers and improving therapeutic performance","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116842","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116842"}}